Telomerase reactivation induces progression of mouse BrafV600E-driven thyroid cancers without telomere lengthening
I. Landa, C. E. Thornton, B. Xu, J. Haase, G. Krishnamoorthy, J. Hao, J. A. Knauf, Z. T. Herbert, M. A. Blasco, R. Ghossein, J. A. Fagin
This study shows that reactivating telomerase in mouse thyroid cancers driven by BrafV600E leads to progression to poorly differentiated tumors without telomere lengthening.
bioRxiv · Jan 24, 2023 · PreprintCancer Biology